journal article·2025-11

Gadolinium-ceria hybrid system enables synergistic alleviation of oxidative stress and metabolic thrombo-inflammation for efficient ischemic stroke treatment

Jin Nan, Chundongqiu Xia, Jingyi Zhang, Yujie Xie, Shuyu Shi, Wei Yang, Meihua Yu, Yu Chen, Jun Zhang

Biomaterials· Volume 322
Publisher page

Abstract

Ischemic stroke is a primary cause of global death and long-term disability. However, current neuroprotective drugs are far from satisfactory in clinical practice. Compelling evidence has emerged that targeting conjoined multiple factors can bring comprehensive treatment. Herein, we report an image-guided gadolinium-ceria nanoparticle-immobilized small therapeutic molecules (ML265) hybrid system for targeted mitigation of oxidative stress and disruption of metabolic reprogramming in cerebral thrombo-inflammation post ischemic stroke. Sub-10 nm hybrid nanotherapeutics sufficiently extravasate through the blood brain barrier (BBB) to pathological brain area. ML265 effectively obstructs the dimerization of metabolic enzyme (pyruvate kinase muscle 2, PKM2) via NF-κB signaling pathway, thus resulting in a significant reduction in the infiltration of neutrophils, monocytes and macrophages companied with declined production of inflammatory cytokines. Concomitantly, the incorporation of gadolinium into ceria nanoparticles allows enhanced antioxidant capability in alleviation of overproduced radicals, and also confers magnetic resonance imaging (MRI) of the injured brain tissue. The therapy is shown to substantially improve the brain recovery in murine ischemic stroke model. Complemented with great tolerance, this strategy offers a safe and effective strategy for ischemic stroke treatment.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (57)

Show source-provided references
1. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 201910.1016/S1474-4422(21)00252-0 ↗
2. Oxidative stress and its role in the pathogenesis of ischaemic stroke10.1111/j.1747-4949.2009.00387.x ↗
3. Edaravone for acute ischaemic stroke
4. Engineering advanced nanomedicines against central nervous system diseases10.1016/j.mattod.2023.08.005 ↗
5. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke10.1016/j.biomaterials.2022.121904 ↗
6. Targeted alleviation of ischemic stroke reperfusion via atorvastatin-ferritin Gd-layered double hydroxide
7. A biomimetic zeolite-based nanoenzyme contributes to neuroprotection in the neurovascular unit after ischaemic stroke via efficient removal of zinc and ROS10.1016/j.actbio.2022.03.018 ↗
8. Bioactive nanoenzyme reverses oxidative damage and endoplasmic reticulum stress in neurons under ischemic stroke10.1021/acsnano.1c07205 ↗
9. Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery10.1021/acsnano.0c07973 ↗
10. Engineering CXCL12 biomimetic decoy-integrated versatile immunosuppressive nanoparticle for ischemic stroke therapy with management of overactivated brain immune microenvironment
11. Inflammation and stroke: an overview10.1007/s13311-016-0483-x ↗
12. Myosin1f-mediated neutrophil migration contributes to acute neuroinflammation and brain injury after stroke in mice10.1186/s12974-019-1465-9 ↗
13. NLRP3 inflammasome-targeting nanomicelles for preventing ischemia-reperfusion-induced inflammatory injury10.1021/acsnano.3c01760 ↗
14. Bacteria-derived outer-membrane vesicles hitchhike neutrophils to enhance ischemic stroke therapy10.1002/adma.202301779 ↗
15. Ligustrazine nanoparticle hitchhiking on neutrophils for enhanced therapy of cerebral ischemia-reperfusion injury
16. Targeted mRNA nanoparticles ameliorate blood-brain barrier disruption postischemic stroke by modulating microglia polarization10.1021/acsnano.3c09817 ↗
17. Brain-targeting, acid-responsive antioxidant nanoparticles for stroke treatment and drug delivery
18. Safety of intraparenchymal injection of allogenic placenta mesenchymal stem cells derived exosome in patients undergoing decompressive craniectomy following malignant middle cerebral artery infarct, a pilot randomized clinical trial10.4103/ijpvm.ijpvm_441_21 ↗
19. Ischemic stroke: experimental models and reality10.1007/s00401-017-1667-0 ↗
20. S100A8/A9: from basic science to clinical application10.1016/j.pharmthera.2016.07.015 ↗
21. Single-cell RNA sequencing unveils Lrg1's role in cerebral ischemia‒reperfusion injury by modulating various cells10.1186/s12974-023-02941-4 ↗
22. Matrix-derived inflammatory mediator N-acetyl proline-glycine-proline is neurotoxic and upregulated in brain after ischemic stroke10.1186/s12974-015-0428-z ↗
23. PARP14 inhibits microglial activation via LPAR5 to promote post-stroke functional recovery10.1080/15548627.2020.1847799 ↗
24. PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke10.1182/blood.2021012322 ↗
25. Immune responses to stroke: mechanisms, modulation, and therapeutic potential10.1172/JCI135530 ↗
26. Ceria-zirconia nanoparticles as an enhanced multi-antioxidant for sepsis treatment10.1002/anie.201704904 ↗
27. Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles10.1039/b615134e ↗
28. The scherrer formula for x-ray particle size determination10.1103/PhysRev.56.978 ↗
29. Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancement10.1038/s41598-018-25390-z ↗
30. Cerium oxide nanoparticles decorated graphene nanosheets for selective detection of dopamine10.1166/jnn.2015.9812 ↗
31. Oxygen vacancies enhanced CeO(2):gd nanoparticles for sensing a tumor vascular microenvironment by magnetic resonance imaging10.1021/acsnano.8b07387 ↗
32. Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating10.1021/nn4026806 ↗
33. Antioxidant cerium oxide nanoparticles in biology and medicine10.3390/antiox5020015 ↗
34. Embedding atomically dispersed manganese/gadolinium dual sites in oxygen vacancy-enriched biodegradable bimetallic silicate nanoplatform for potentiating catalytic therapy
35. Chemistry of mri contrast agents: current challenges and new frontiers10.1021/acs.chemrev.8b00363 ↗
36. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents10.1039/b510982p ↗
37. Water adsorption on the stoichiometric and reduced CeO2(111) surface: a first-principles investigation10.1039/b901831j ↗
38. Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment10.1080/15548627.2023.2213984 ↗
39. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death10.1038/msb.2012.20 ↗
40. The immunology of acute stroke10.1038/nrneurol.2012.98 ↗
41. PKM2, cancer metabolism, and the road ahead10.15252/embr.201643300 ↗
42. Custom-made ceria nanoparticles show a neuroprotective effect by modulating phenotypic polarization of the microglia10.1002/anie.201802309 ↗
43. Myeloid cell PKM2 deletion enhances efferocytosis and reduces atherosclerosis10.1161/CIRCRESAHA.121.320704 ↗
44. M-type pyruvate kinase 2 (PKM2) tetramerization alleviates the progression of right ventricle failure by regulating oxidative stress and mitochondrial dynamics10.1186/s12967-023-04780-6 ↗
45. Overcoming the blood-brain barrier: the role of nanomaterials in treating neurological diseases10.1002/adma.201801362 ↗
46. Selective liposomal transport through blood brain barrier disruption in ischemic stroke reveals two distinct therapeutic opportunities10.1021/acsnano.9b01808 ↗
47. Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke10.1152/ajpcell.00136.2018 ↗
48. Animal models of ischemic stroke and their application in clinical research
49. Elimination pathways of nanoparticles10.1021/acsnano.9b01383 ↗
50. Stroke induces disease-specific myeloid cells in the brain parenchyma and pia10.1038/s41467-022-28593-1 ↗
51. Interaction of microglia with infiltrating immune cells in the different phases of stroke10.1111/bpa.12911 ↗
52. Arginase 1 regulation of nitric oxide production is key to survival of trophic factor-deprived motor neurons10.1523/JNEUROSCI.0728-06.2006 ↗
53. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia10.1161/01.CIR.0000155622.68580.DC ↗
54. Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke10.1007/s00401-014-1355-2 ↗
55. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain10.1016/S0165-5728(02)00184-4 ↗
56. Brain dendritic cells in ischemic stroke: time course, activation state, and origin10.1016/j.bbi.2009.11.002 ↗
57. Nanodrugs: pharmacokinetics and safety10.2147/IJN.S38378 ↗